Bulevirtide
Hepcludex (bulevirtide) is a protein pharmaceutical. Bulevirtide was first approved as Hepcludex on 2020-07-31. It has been approved in Europe to treat chronic hepatitis d.
Trade Name | Hepcludex |
---|---|
Common Name | Bulevirtide |
Indication | chronic hepatitis d |
Drug Class | Peptides: antiviral peptides; antivirals |
